39
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Postsurgical recurrence of hepatocellular carcinoma (HCC) is frequent and fatal. Adoptive immunotherapy is active against HCC. We assessed whether postoperative immunotherapy could lower the frequency of recurrence.

          Related collections

          Author and article information

          Journal
          Lancet
          Lancet (London, England)
          Elsevier BV
          0140-6736
          0140-6736
          Sep 02 2000
          : 356
          : 9232
          Affiliations
          [1 ] Department of Surgery, National Cancer Centre Research Institute, University of Tokyo, Japan. takayamat-2su@h.u-tokyo.ac.jp
          Article
          S0140-6736(00)02654-4
          10.1016/S0140-6736(00)02654-4
          11022927
          34527e08-6fb3-4359-87cb-e186cfcee00a
          History

          Comments

          Comment on this article